Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma (Q73810672)
Jump to navigation
Jump to search
scientific article published on 01 March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma |
scientific article published on 01 March 2001 |
Statements
Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma (English)